按 Enter 到主內容區
  • facebook
  • line
  • twitter
  • 列印
  • 回上一頁

CCMP101-RD-013 進行兩岸中藥濃縮製劑(台灣)及配方顆粒(大陸)相關比較研究

  • 資料來源:中醫藥司
  • 建檔日期:102-08-07
  • 更新時間:106-06-12

進行兩岸中藥濃縮製劑(台灣)及配方顆粒(大陸)相關比較研究

陳甘霖
中華民國製藥發展協會
本計畫透過探討中藥濃縮製劑(台灣)及配方顆粒(大陸)相關比較研究、兩岸交流研討會、專家座談會及業者座談會的方式,商討兩岸中藥濃縮製劑相關管理法規,研究進行其合作模式及可行性。
本計畫期能透過兩岸研究機構及生產企業之交流合作,除分享雙方於中藥濃縮製劑及配方製劑之管理法規與經驗外,亦涉及中醫藥在平等互惠的基礎上相互洽商,達成務實合作之目標,以利未來中醫藥研究之推動。
關鍵字:中藥濃縮製劑、配方顆粒、兩岸中醫藥管理法規

A cross-strait comparative study on Chinese medicine preparations--oncentrated extracts in Taiwan and granules in Mainland

Ganlin Chen
Chinese Pharmaceutical Manufacture and Development Association
Through this project “A cross-strait comparative study on Chinese medicine preparations-- concentrated extracts in Taiwan and granules in Mainland”, the following activities will be organized.
Via cross-strait exchanges conference, experts symposium, and industrial forums, to discuss the regulations on concentrated preparations of traditional Chinese medicine for both sides. Also, the cooperation in relevant models and feasibility for cross-strait relations will be studied.
This plan views the cooperation and interaction of research institutions and production enterprises. In addition to the two sides could share the regulations and experiences of traditional Chinese medicine preparations. On the basis of equality and mutual benefit, the cross-strait could discuss practical cooperation to achieve the goal and to facilitate the follow-up studies of Chinese medicine to the competent authorities.
關鍵字:Chinese medicine concentrated extracts, Chinese medicine granules, A cross-strait regulations in the Chinese medicine